Next Generation Sequencing Market Research, Global Industry Top Key Players (Roche Holding Ag, Qiagen N.V., Knome.Inc., Perkinelmer.Inc. and Partek.Inc.,)

The Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to 2022. The growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. However, factors such as accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. The rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

Looking for More Information on This Market Get Free Sample Report @ http://www.researchformarkets.com/sample/next-generation-sequencing-global-market-4554                           

Some of the key players in the market include:

Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc., Partek, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd., Macrogen Inc., Life Technologies Corporation, Illumina, Inc., Genomatix Software GmbH, GATC Biotech Ag., Eurofins Scientific, DNASTAR Inc., Biomatters, Ltd., Beijing Genomics Institute and Agilent Technologies, Inc.

In technology, sequencing by synthesis (SBS) segment is anticipated to move with a highest CAGR during forecast period. Diagnostics in application segment holds the largest share and is expected to grow at highest CAGR during forecast period. Research institutions held the largest market share in end user segment. North America dominates the global next generation sequencing market followed by Europe owing to rising government support towards research and development. Asia pacific is expected to grow at a faster rate during the forecast period due to the unmet market demand and increasing investments for development of healthcare.

Platforms Covered:

Sequencing Services
Sequencing Platforms
ION S5 & S5 Xl
ION PGM
ION Proton

Technologies Covered:

Sequencing By Ligation (SBL)
Single-Molecule Real-Time Sequencing (SMRT)
Sequencing By Synthesis (SBS)
Pyrosequencing
ION Semiconductor Sequencing
Other Technologies

End Users Covered:

Hospitals and clinics
Biotech & Pharma Firms
Research institutions
Other End Users

Applications Covered:

Personalized medicines, Drug Discovery, Diagnostics, Agriculture & Animal Research, Prenatal Testing, Biomarker Discovery, HLA Testing, Infectious Diseases, Genetic Screening, Oncology, Idiopathic Diseases and Other Applications

Regions Covered:

North America
Europe
Asia Pacific
Rest of the World

Place a Purchase Order for Next Generation Sequencing @ http://www.researchformarkets.com/buy-now/next-generation-sequencing-global-market-4554/one

Table of Content

1 Executive Summary         

2 Preface           

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

3 Market Trend Analyses        

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

4 Porters Five Force Analysis         

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

5 Global Next Generation Sequencing Market, By Platforms    

5.1 Introduction

5.2 Sequencing Services

5.3 Sequencing Platforms

6 Global Next Generation Sequencing Market, By Technology    

 6.1 Introduction   

 6.2 Sequencing By Ligation (SBL)   

 6.3 Single-Molecule Real-Time Sequencing (SMRT)   

7 Global Next Generation Sequencing Market, By End User    

7.1 Introduction

7.2 Hospitals and clinics

7.3 Biotech & Pharma Firms

7.4 Research institutions

7.5 Other End Users

8 Global Next Generation Sequencing Market, By Application    

8.1 Introduction

8.2 Personalized Medicines

8.3 Drug Discovery

9 Global Next Generation Sequencing Market, By Geography    

9.1 North America

9.2 Europe

9.3 Asia Pacific

10 Key Developments    

10.1 Agreements, Partnerships, Collaborations and Joint Ventures

10.2 Acquisitions & Mergers

10.3 New Product Launch

10.4 Expansions

10.5 Other Key Strategies

11 Company Profiling    

11.1 Roche Holding Ag

11.2 Qiagen N.V.

11.3 Knome, Inc.

11.4 Perkinelmer, Inc.

11.5 Partek, Inc.

11.6 Pacific Biosciences

11.7 Oxford Nanopore Technologies, Ltd.

11.8 Macrogen Inc.

11.9 Life Technologies Corporation

11.10 Illumina, Inc.

Looking for more insights from this report @ http://www.researchformarkets.com/reports/next-generation-sequencing-global-market-4554

About Research for Markets:
Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.
Our purpose is to serve you, the most customized in-depth Market access data. Our plethora of titles made us one of the most searched market research library across the globe. We work with the most esteemed Publishers around the globe who caters vast industries. We are quick and fragile, when it comes to your various queries, and we ensure our team caters your needs to the best of our abilities, we promise to stay by your side for both pre and post sales servicing, as we believe in long everlasting symbiotic relationship.

Contact:
Mr. A Naidu
Research for Markets
Tel: +44 8000-4182-37 (UK)
Email: alan.naidu@researchformarkets.com

This release was published on openPR.